Donor Login
Contact Us
Breakthrough T1D
About
Investment Strategy
Portfolio
Our Team
News
Donor Login
Get in Touch
News and Press
Matchpoint Therapeutics Announces $150 Million Series B Financing to Advance Pipeline of First-In-Class Oral Small Molecules for Autoimmune and Inflammatory Diseases
October 07, 2026 |
Watertown, Mass.
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
September 09, 2026 |
San Diego
COUR Pharma Announces Closing of $50 Million Series B
June 18, 2026 |
Chicago
The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes (“T1D”) Therapies
January 21, 2026
Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Diseases
October 28, 2025
